Common intravenous anesthetics such as propofol and etomidate usually require additional pain medicines. Propofol and etomidate enhance GABA-A receptors, which act as brakes on nerve-cell activity, but generally do not relieve pain at nonsedating doses. In addition, propofol is known to commonly cause low blood pressure and slowed (or sometimes stopped) breathing, while etomidate can cause adrenal suppression by lowering cortisol production, potentially causing severe or life-threatening effects. Therefore, researchers are looking for suitable alternatives.